PT - JOURNAL ARTICLE AU - Abeed Sarker AU - Sahithi Lakamana AU - Whitney Hogg-Bremer AU - Angel Xie AU - Mohammed Ali Al-Garadi AU - Yuan-Chi Yang TI - Self-reported COVID-19 symptoms on Twitter: An analysis and a research resource AID - 10.1101/2020.04.16.20067421 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.16.20067421 4099 - http://medrxiv.org/content/early/2020/05/18/2020.04.16.20067421.short 4100 - http://medrxiv.org/content/early/2020/05/18/2020.04.16.20067421.full AB - Objective To mine Twitter to quantitatively analyze COVID-19 symptoms self-reported by users, compare symptom distributions against clinical studies, and create a symptom lexicon for the research community.Materials and methods We retrieved tweets using COVID-19-related keywords, and performed semi-automatic filtering to curate self-reports of positive-tested users. We extracted COVID-19-related symptoms mentioned by the users, mapped them to standard concept IDs (UMLS), and compared the distributions to those reported in early studies from clinical settings.Results We identified 203 positive-tested users who reported 1002 symptoms using 668 unique expressions. The most frequently-reported symptoms were fever/pyrexia (66.1%), cough (57.9%), body ache/pain (42.7%), fatigue (42.1%), headache (37.4%), and dyspnea (36.3%) amongst users who reported at least 1 symptom. Mild symptoms, such as anosmia (28.7%) and ageusia (28.1%) were frequently reported on Twitter, but not in clinical studies.Conclusion The spectrum of COVID-19 symptoms identified from Twitter may complement those identified in clinical settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementTBAAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe symptom lexicon will be made available via the link provided. https://sarkerlab.org/covid_sm_data_bundle/